Company intelligence / Profile preview

Vetana Animal Health

Ownership: Private
Development stage: Preclinical

Overview

Vetana Animal Health is developing a non‐viral gene therapy for treating pathologic inflammation and associated pain/mobility issues in dogs. The company has ongoing clinical studies targeting canine joint pain but has not yet published pivotal results.

Therapeutic areas: Rheumatology
Modalities: Gene therapy (non-viral gene therapy platform)
Industry: Veterinary

Beyond the preview

Go deeper on Vetana Animal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vetana Animal Health.

Explore the full profile